quinoxalines has been researched along with Brain Edema in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mo, L; Song, Z; Wan, Y; Wang, K; Wang, Y; Xue, Z | 1 |
| Ji, S; Pang, L; Xing, J | 1 |
| Alleyne, CH; Dhandapani, KM; King, MD | 1 |
| Khama-Murad, AKh | 1 |
| Miyata, K; Sasamata, M; Suzuki, M; Terai, K; Yamaguchi, T; Yatsugi, Si | 1 |
| Asakura, T; Atsumi, T; Furukawa, T; Hoshino, S; Kobayashi, S; Takahashi, M; Teramoto, A | 1 |
| Asakura, T; Atsumi, T; Furukawa, T; Hoshino, S; Kobayashi, S; Takahashi, M; Teramoto, A; Yamamoto, Y | 1 |
| Johansson, BB; Westergren, I | 3 |
| Boysen, G; Overgaard, K; Pedersen, H; Sereghy, T | 1 |
| Chan, PH; Chang, LH; Espanol, MT; James, TL; Litt, L; Weinstein, PR; Xu, Y | 1 |
| Lo, EH; Mandeville, JB; Pierce, AR; Rosen, BR | 1 |
| Ikeda, Y; Kondo, K; Takamatsu, H; Umemura, K | 1 |
| Andreas, K; Häntzschel, A | 1 |
15 other study(ies) available for quinoxalines and Brain Edema
| Article | Year |
|---|---|
Calcium-sensing receptor antagonist NPS2390 attenuates neuronal apoptosis though intrinsic pathway following traumatic brain injury in rats.
Topics: Adamantane; Animals; Apoptosis; bcl-2-Associated X Protein; Brain; Brain Edema; Brain Injuries, Traumatic; Caspase 3; Cytochromes c; Gene Expression Regulation; Infusions, Subcutaneous; Male; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Signal Transduction | 2017 |
Amiloride Alleviates Neurological Deficits Following Transient Global Ischemia and Engagement of Central IL-6 and TNF-α Signal.
Topics: Acid Sensing Ion Channels; Amiloride; Animals; Asphyxia; Brain Damage, Chronic; Brain Edema; Caspase 3; Caspase 9; Drug Evaluation, Preclinical; Hippocampus; Hydrazines; Interleukin-6; Ischemic Attack, Transient; Male; Quinoxalines; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Up-Regulation | 2019 |
TNF-alpha receptor antagonist, R-7050, improves neurological outcomes following intracerebral hemorrhage in mice.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Cerebral Hemorrhage; Hematoma; Male; Mice; Neuroprotective Agents; Quinoxalines; Receptors, Tumor Necrosis Factor, Type I; Triazoles; Tumor Necrosis Factor-alpha | 2013 |
[Edema in nervous tissue studied on model of hemorrhagic stroke in vitro].
Topics: 2-Amino-5-phosphonovalerate; Animals; Brain Edema; Disease Models, Animal; Excitatory Amino Acid Antagonists; In Vitro Techniques; Intracranial Hemorrhage, Hypertensive; Nerve Tissue; Olfactory Pathways; Quinoxalines; Rats; Rats, Inbred SHR; Receptors, Ionotropic Glutamate; Stroke; Synaptic Potentials; Time Factors | 2011 |
Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model.
Topics: Animals; Atrophy; Brain Edema; Brain Infarction; Cerebral Hemorrhage; Collagenases; Dose-Response Relationship, Drug; Hematoma; Heparin; Imidazoles; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 2003 |
The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in rats.
Topics: Animals; Body Temperature; Brain Edema; Brain Injuries; Cerebral Cortex; Glutamic Acid; Imidazoles; Male; Models, Animal; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Recovery of Function | 2003 |
The glutamate AMPA receptor antagonist, YM872, attenuates regional cerebral edema and IgG immunoreactivity following experimental brain injury in rats.
Topics: Animals; Body Water; Brain; Brain Edema; Brain Injuries; Imidazoles; Immunoglobulin G; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 2003 |
Blockade of AMPA receptors reduces brain edema following opening of the blood-brain barrier.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Dizocilpine Maleate; Evans Blue; Excitatory Amino Acid Antagonists; Injections, Intravenous; Male; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Specific Gravity; Staining and Labeling | 1993 |
Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
Topics: Animals; Brain Edema; Cerebral Infarction; Cerebrovascular Circulation; Fibrinolysis; Intracranial Embolism and Thrombosis; Male; Paralysis; Quinoxalines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Weight Loss | 1993 |
Pharmacological reduction of brain edema induced by intracarotid infusion of protamine sulphate: a comparison between a free radical scavenger and an AMPA receptor antagonist.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Cerebral Cortex; Infusions, Intra-Arterial; Lipid Peroxides; Male; Phenothiazines; Pregnatrienes; Premedication; Protamines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Serum Albumin; Specific Gravity | 1994 |
Modulation of edema by dizocilpine, kynurenate, and NBQX in respiring brain slices after exposure to glutamate.
Topics: Animals; Brain Edema; Cerebral Cortex; Culture Techniques; Dizocilpine Maleate; Energy Metabolism; Glutamic Acid; Kynurenic Acid; Magnetic Resonance Spectroscopy; Organ Size; Quinoxalines; Rats; Receptors, AMPA; Receptors, Glutamate; Sodium Channels | 1994 |
Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships.
Topics: Animals; Body Water; Brain Damage, Chronic; Brain Edema; Brain Ischemia; Cerebral Infarction; Diffusion; Excitatory Amino Acid Antagonists; Magnetic Resonance Imaging; Male; Nerve Tissue Proteins; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1997 |
Neuroprotective effects depend on the model of focal ischemia following middle cerebral artery occlusion.
Topics: Animals; Brain Edema; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Electrocoagulation; Immunosuppressive Agents; Injections, Intraperitoneal; Injections, Intravenous; Intracranial Embolism and Thrombosis; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Tacrolimus | 1998 |
Non-N-methyl-D-aspartate (NMDA) receptor antagonist 1,2,3, 4-tetrahydro-6-nitro-2,3-dioxo-benzo(f)quinoxaline-7-sulphonamide (NBQX) decreases functional disorders in cytotoxic brain oedema.
Topics: Animals; Behavior, Animal; Brain; Brain Edema; Excitatory Amino Acid Antagonists; Hexachlorophene; Male; Motor Activity; Motor Skills Disorders; Piperidines; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2000 |
NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema.
Topics: Animals; Blood Pressure; Blood-Brain Barrier; Brain; Brain Edema; Glutamates; Glutamic Acid; Hematocrit; Male; Oxadiazoles; Protamines; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, AMPA; Receptors, Neurotransmitter; Serum Albumin | 1992 |